Current Neuro-Oncology

Volume 4 Number 2
28 February 2002

Home > Publications > Current Neuro-Oncology > Volume 4, Year 2002 > Number 2, 28 February

Fahlbusch R, Schott W.
Pterional surgery of meningiomas of the tuberculum sellae and planum sphenoidale: surgical results with special consideration of ophthalmological and endocrinological outcomes.
J Neurosurg. 2002 Feb;96(2):235-43
. doi: 10.3171/jns.2002.96.2.0235. PMID: 11838796. Observational study. ˍ

Fontaine D, Capelle L, Duffau H.
Somatotopy of the supplementary motor area: evidence from correlation of the extent of surgical resection with the clinical patterns of deficit.
Neurosurgery. 2002 Feb;50(2):297-303. doi: 10.1097/00006123-200202000-00011. PMID: 11844264. Observational study.

Gerlach R, Kieslich M, van de Nes J, Galow W, Seifert V.
Supratentorial leptomeningeal metastasis of a medulloblastoma without cerebellar tumor recurrence.
Acta Neurochir (Wien). 2002 Feb;144(2):201-4. doi: 10.1007/s007010200025. PMID: 11862522. Case report.

Pompili A, Caperle M, Pace A, Ramazzotti V, Raus L, Jandolo B, Occhipinti E.
Quality-of-life assessment in patients who had been surgically treated for cerebellar pilocytic astrocytoma in childhood.
J Neurosurg. 2002 Feb;96(2):229-34. doi: 10.3171/jns.2002.96.2.0229. PMID: 11838795. Observational study.

Prayson RA, Chowdhary S, Woodhouse S, Hanson M, Nair S.
Collision of a syncytial meningioma and malignant astrocytoma.
Ann Diagn Pathol. 2002 Feb;6(1):44-8. doi: 10.1053/adpa.2002.30612. PMID: 11842378. Case report.

Taylor SA, Rankin C, Townsend JJ, Craig JB, Vance RB, Solank DL, Brown TD, Jaeckle K; Southwest Oncology Group.
Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group study.
Invest New Drugs. 2002 Feb;20(1):113-5. doi: 10.1023/a:1014488922368. PMID: 12003186. Interventional study. ˍ

Viñolas N, Gil M, Verger E, Villá S, Pujol T, Ceral L, García M, Graus F.
Pre-irradiation semi-intensive chemotherapy with carboplatin and cyclophosphamide in malignant glioma: a phase II study.
Anticancer Drugs. 2002 Feb;13(2):163-7. doi: 10.1097/00001813-200202000-00008. PMID: 11901309. Interventional study.

Voulgaris S, Partheni M, Karamouzis M, Dimopoulos P, Papadakis N, Kalofonos HP.
Intratumoral doxorubicin in patients with malignant brain gliomas.
Am J Clin Oncol. 2002 Feb;25(1):60-4. doi: 10.1097/00000421-200202000-00013. PMID: 11823699. Observational study.

Karim AB, Afra D, Cornu P, Bleehan N, Schraub S, De Witte O, Darcel F, Stenning S, Pierart M, Van Glabbeke M.
Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis.
Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):316-24
. doi: 10.1016/s0360-3016(01)02692-x. PMID: 11872276. Interventional study. ˍ

Merchant TE, Zhu Y, Thompson SJ, Sontag MR, Heideman RL, Kun LE.
Preliminary results from a Phase II trail of conformal radiation therapy for pediatric patients with localised low-grade astrocytoma and ependymoma.
Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):325-32. doi: 10.1016/s0360-3016(01)01807-7. PMID: 11872277. Interventional study.

Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay JL, Sposto R; Children's Cancer Group.
Expression of p53 and prognosis in children with malignant gliomas.
N Engl J Med. 2002 Feb 7;346(6):420-7. doi: 10.1056/NEJMoa012224. PMID: 11832530. Observational study.

Huang E, Teh BS, Strother DR, Davis QG, Chiu JK, Lu HH, Carpenter LS, Mai WY, Chintagumpala MM, South M, Grant WH 3rd, Butler EB, Woo SY.
Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.
Int J Radiat Oncol Biol Phys. 2002 Feb 8;52(3):599-605
. doi: 10.1016/s0360-3016(01)02641-4. PMID: 11849779. Observational study. ˍ


Grana C, Chinol M, Robertson C, Mazzetta C, Bartolomei M, De Cicco C, Fiorenza M, Gatti M, Caliceti P, Paganelli G.
Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study.
Br J Cancer. 2002 Feb 8;86(2):207-12∟. doi: 10.1038/sj.bjc.6600047∟. PMID: 11870507∟. Interventional study.

Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS.
Quantitatively determined survivin expression levels are of prognostic value in human gliomas.
J Clin Oncol. 2002 Feb 15;20(4):1063-8. doi: 10.1200/JCO.2002.20.4.1063. PMID: 11844831. Observational study.